⌘K

Login Start Free

Home/Filings/4/0000897069-24-000269

4//SEC Filing

Young David 4

Accession 0000897069-24-000269

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:30 PM ET

Size

6.5 KB

Accession

0000897069-24-000269

Insider Transaction Report

Form 4

Period: 2024-02-07

Processa Pharmaceuticals, Inc.PCSA

DirectorPres. Research & Development

Transactions

Purchase
Common Stock
2024-02-07$2.45/sh+21,000$51,526→ 79,387 total

Holdings

Common Stock
(indirect: By Family Entities)
10,786
Common Stock
(indirect: By LLC)
18,544
Common Stock
(indirect: By Trust)
30,985

Documents

1 file

4
form4.xmlPrimary

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001378166

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 4:30 PM ET
Size: 6.5 KB

View on SEC.gov